{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:10Z","timestamp":1791295750841,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.drudis.2008.01.006","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T11:58:58Z","timestamp":1205236738000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["From a glucocentric to a lipocentric approach towards metabolic syndrome"],"prefix":"10.1016","volume":"13","author":[{"given":"Shivani","family":"Mittra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay S.","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip K.","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2008.01.006_bib1","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1038\/oby.2006.280","article-title":"New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy","volume":"14","author":"Petersen","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.drudis.2008.01.006_bib2","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1016\/j.amjmed.2006.01.009","article-title":"Etiology of insulin resistance","volume":"119","author":"Petersen","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drudis.2008.01.006_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.02.051","article-title":"Treatment of insulin resistance diabetes mellitus","volume":"409","author":"Lebovitz","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2008.01.006_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tem.2005.06.001","article-title":"New therapeutic options for the metabolic syndrome. What's next?","volume":"16","author":"Flordellis","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s001250050793","article-title":"The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study","volume":"40","author":"Charles","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2008.01.006_bib6","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.2337\/dc06-0138","article-title":"Effects of traditional and Western environments on prevalence of Type 2 Diabetes in Pima Indians in Mexico and the U.S.","volume":"29","author":"Schulz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2008.01.006_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose-fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2008.01.006_bib8","doi-asserted-by":"crossref","first-page":"E977","DOI":"10.1152\/ajpendo.1999.276.5.E977","article-title":"Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo","volume":"276","author":"Szczepaniak","year":"1999","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diabetes.47.3.381","article-title":"13C\/31P NMR studies on the metabolism of insulin resistance in obesity","volume":"47","author":"Petersen","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2008.01.006_bib10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI115686","article-title":"31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin dependent diabetes mellitus","volume":"89","author":"Rothman","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1073\/pnas.92.4.983","article-title":"Decreased muscle glucose transport\/phosphorylation is an early defect in the pathogenesis of non- insulin dependent diabetes mellitus","volume":"92","author":"Rothman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2008.01.006_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1152\/physiol.00007.2004","article-title":"Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy","volume":"19","author":"Shulman","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.drudis.2008.01.006_bib13","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.2337\/db05-1511","article-title":"Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker fatty rats","volume":"55","author":"Fujimoto","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2008.01.006_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.143.2.8623","article-title":"Minireview: secondary \u03b2-cell failure in Type 2 diabetes \u2013 a convergence of glucotoxicity and lipotoxicity","volume":"143","author":"Poitout","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2008.01.006_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.RES.0000259589.34348.74","article-title":"Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?","volume":"100","author":"Kanter","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2008.01.006_bib16","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0802853","article-title":"Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and Type II diabetes mellitus","volume":"28","author":"Heilbronn","year":"2004","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.drudis.2008.01.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2006.00590.x","article-title":"Ectopic fat accumulation and metabolic syndrome","volume":"9","author":"Rasouli","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.arr.2006.03.004","article-title":"Lipotoxicity, overnutrition and energy metabolism in aging","volume":"5","author":"Slawik","year":"2006","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.drudis.2008.01.006_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","article-title":"Free fatty acids and pathogenesis of Type 2 diabetes mellitus","volume":"11","author":"Bergman","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI7815","article-title":"Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo","volume":"106","author":"Getty","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib21","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/j.febslet.2007.06.044","article-title":"Metabolic stress in insulin's target cells leads to reactive oxygen species accumulation \u2013 a hypothetical common pathway causing insulin resistance","volume":"581","author":"Eriksson","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drudis.2008.01.006_bib22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nm1611","article-title":"Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome","volume":"13","author":"Kuo","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2008.01.006_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.beem.2005.07.004","article-title":"Human fat cell lipolysis: biochemistry, regulation and clinical role","volume":"19","author":"Arner","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib24","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1152\/ajpendo.00203.2004","article-title":"Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance","volume":"288","author":"Kabir","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib25","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1152\/ajpendo.00306.2005","article-title":"Effect of portal free fatty acid elevation on insulin clearance and hepatic glucose flux","volume":"290","author":"Yoshii","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/cr.2007.48","article-title":"Fat poetry: a kingdom for PPAR\u03bb","volume":"17","author":"Anghel","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.drudis.2008.01.006_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.107.160457","article-title":"Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America","volume":"101","author":"Szczepaniak","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2008.01.006_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drudis.2008.01.006_bib29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI200419511","article-title":"Site and mechanism of leptin action in a rodent form of congenital lipodystrophy","volume":"113","author":"Asilmaz","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib30","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2174\/138161207781039661","article-title":"Visceral fat as a target of highly active antiretroviral therapy \u2013 associated metabolic syndrome","volume":"13","author":"Barbaro","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2008.01.006_bib31","doi-asserted-by":"crossref","first-page":"E1064","DOI":"10.1152\/ajpendo.00296.2003","article-title":"Insulin\/IGF-1 signaling pathway: an evolutionarily conserved mechanism longevity from yeast to humans","volume":"285","author":"Barbieri","year":"2003","journal-title":"Am. J. Physiol. Encocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat. Rev."},{"key":"10.1016\/j.drudis.2008.01.006_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/447525a","article-title":"The two faces of fat","volume":"447","author":"Powell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.01.006_bib35","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2006.04.173","article-title":"Co-culture with fat cells induces insulin resistance in primary hepatocytes","volume":"345","author":"Wang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2008.01.006_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib37","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.drudis.2008.01.006_bib38","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0021-9258(18)41516-5","article-title":"Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT-4 selectively in adipose tissue","volume":"268","author":"Shepherd","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.01.006_bib39","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1210\/endo.138.4.5043","article-title":"Amelioratio of insulin resistance in STZ diabetic mice by transgenic overexpression of GLUT-4 driven by an adipose- specific promoter","volume":"138","author":"Tozzo","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2008.01.006_bib40","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI8305","article-title":"Redistribution of substrates to adipose tissue in mice with selective insulin resistance in muscle promoting obesity","volume":"105","author":"Kim","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib43","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/en.2005-0969","article-title":"MCP-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscles","volume":"147","author":"Sell","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2008.01.006_bib44","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2337\/diabetes.54.7.2003","article-title":"Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance inducing factor","volume":"54","author":"Dietze-Schroeder","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2008.01.006_bib45","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00125-007-0626-z","article-title":"Characterization of insulin resistant phenotype of cultured rat primary adipose cell","volume":"50","author":"Xiang","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2008.01.006_bib46","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammatory, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.drudis.2008.01.006_bib47","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1074\/jbc.M411860200","article-title":"Involvement of endoplasmic stress in insulin resistance and diabetes","volume":"280","author":"Nakatani","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.01.006_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endothelium reticulum stress links obesity, insulin action and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.01.006_bib50","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1194\/jlr.R700007-JLR200","article-title":"Adipocyte stress: THE endoplasmic reticulum and metabolic disease","volume":"48","author":"Gregor","year":"2007","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.drudis.2008.01.006_bib51","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.biocel.2006.01.004","article-title":"Role of oxidative stress, endoplasmic reticulum stress and c-Jun-N-terminal kinase in pancreatic \u03b2-cell dysfunction and insulin resistance","volume":"38","author":"Kaneto","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.drudis.2008.01.006_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tem.2006.10.010","article-title":"The adipocyte-myocyte axis in insulin resistance","volume":"17","author":"Sell","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib54","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2337\/db06-0783","article-title":"Impaired mitochondrial substrate oxidation in muscle of insulin resistant offspring of type 2 diabetic patients","volume":"56","author":"Befroy","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2008.01.006_bib55","doi-asserted-by":"crossref","first-page":"E744","DOI":"10.1152\/ajpendo.00355.2002","article-title":"N-acetylcysteine and taurine prevent hyperglycaemia- induced insulin resistance in vivo: possible role of oxidative stress","volume":"285","author":"Haber","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cardfail.2006.10.013","article-title":"Effects of combined candesartan and ACE inhibitors on bnp, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure","volume":"13","author":"White","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.drudis.2008.01.006_bib57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2215\/CJN.03470807","article-title":"Rosiglitazone: Opening Pandora's Black Box?","volume":"2","author":"Gilbert","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.drudis.2008.01.006_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/94156","article-title":"Therapeutic potential of retinoid X receptor modulators for treatment of metabolic syndrome","volume":"2007","author":"Pinaire","year":"2007","journal-title":"PPAR Res."},{"key":"10.1016\/j.drudis.2008.01.006_bib59","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drudis.2008.01.006_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2008.01.006_bib61","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M510258200","article-title":"The farsenoid X receptor modulates adiposity and peripheral insulin sensitivity in mice","volume":"281","author":"Cariou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.01.006_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tem.2005.11.008","article-title":"Adipose tissue as source and target for novel therapies","volume":"17","author":"Klein","year":"2006","journal-title":"Trends Endocrinol. Met."},{"key":"10.1016\/j.drudis.2008.01.006_bib63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol- binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kloting","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1471-4892(03)00068-7","article-title":"JNK: a new therapeutic target for diabetes","volume":"3","author":"Bennett","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2008.01.006_bib65","doi-asserted-by":"crossref","first-page":"16454","DOI":"10.1073\/pnas.0607626103","article-title":"Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin receptor substrates","volume":"103","author":"Solinas","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.drudis.2008.01.006_bib66","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm1111","article-title":"Possible novel therapy for diabetes with cell permeable JNK-inhibitory peptide","volume":"10","author":"Kaneto","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2008.01.006_bib67","doi-asserted-by":"crossref","unstructured":"Wellen, K.E. et al. (2007) Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129, 537\u2013548","DOI":"10.1016\/j.cell.2007.02.049"},{"key":"10.1016\/j.drudis.2008.01.006_bib68","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature05486","article-title":"Sirtuins as potential targets for metabolic syndrome","volume":"444","author":"Guarente","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib69","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature06261","article-title":"Small molecule activators of SIRT1 as therapeutics for treatment of type 2 diabetes","volume":"450","author":"Milne","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.pharmtox.47.120505.105304","article-title":"AMP-activated protein kinase as a drug target","volume":"47","author":"Hardie","year":"2007","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2008.01.006_bib71","doi-asserted-by":"crossref","first-page":"32549","DOI":"10.1074\/jbc.M706536200","article-title":"Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase","volume":"282","author":"Goransson","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.01.006_bib72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes","volume":"1","author":"Maeda","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.drudis.2008.01.006_bib73","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty acid-binding- protein aP2","volume":"447","author":"Furuhashi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.01.006_bib74","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmcl.2006.12.044","article-title":"Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)","volume":"17","author":"Sulsky","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2008.01.006_bib75","first-page":"695","article-title":"Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity","volume":"3","author":"Shi","year":"2004","journal-title":"Nat. Rev."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644608000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644608000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:01:47Z","timestamp":1761220907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644608000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":75,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1359644608000147"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2008.01.006","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From a glucocentric to a lipocentric approach towards metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2008.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}